List of works - Pieter M van Baal

A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

scientific article published on 01 October 2018

Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data

scientific article

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

scientific article published on 4 August 2007

Cost-effectiveness of lifestyle modification in diabetic patients

scientific article published on 12 May 2009

DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact Assessments

scientific article

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

scientific article

Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life.

scientific article published on 14 September 2014

Disability weights for comorbidity and their influence on health-adjusted life expectancy

scientific article

Disease prevention: saving lives or reducing health care costs?

scientific article

Does living longer in good health facilitate longer working lives? The relationship between disability and working lives

scientific article published on 7 April 2015

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.

scientific article

Economic evaluation and the postponement of health care costs.

scientific article published in April 2011

Economics and public health: engaged to be happily married!

article

Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty

scientific article

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.

scientific article

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.

scientific article published in April 2011

Forecasting differences in life expectancy by education.

scientific article

Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patterns

scientific article published on August 2012

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

scientific article published on 01 February 2019

Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis

scientific article published on December 2014

Future costs in economic evaluation. A comment on Lee.

scientific article published on 25 July 2008

Future unrelated medical costs need to be considered in cost effectiveness analysis

scientific article published on 18 April 2018

Health care input constraints and cost effectiveness analysis decision rules.

scientific article published on 27 January 2018

Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level

scientific article published on 16 April 2016

Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective

article by Pieter M van Baal published 15 June 2012 in Heart

Increasing tobacco taxes: A cheap tool to increase public health

article

Indirect estimation of chronic disease excess mortality.

scientific article

Lifestyle intervention: from cost savings to value for money.

scientific article

Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.

scientific article published on October 2008

Mortality risk associated with disability: a population-based record linkage study

scientific article published on 20 October 2011

PAID 1.0 in Practice

scientific article published on June 1, 2011

Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

scientific article published in May 2013

Probabilistic sensitivity analysis: be a Bayesian.

scientific article published on 20 August 2009

Quality of life and time to death: have the health gains of preventive interventions been underestimated?

scientific article published on 23 October 2014

Realistic Spatial Backcloth is not that Important in Agent Based Simulation Research

Should cost effectiveness analyses for NICE always consider future unrelated medical costs?

scientific article

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention

scientific article

The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA).

scientific article

The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries.

scientific article

The cost-effectiveness of increasing alcohol taxes: a modelling study.

scientific article

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action

scientific article published on 03 August 2007

Time to death and the forecasting of macro-level health care expenditures: some further considerations

scientific article published on 29 August 2012

Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach.

scientific article

To die with or from heart failure: a difference that counts

Trends in Dutch hospital spending by age and disease 1994-2010.

scientific article published on 20 November 2014

Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.

scientific article

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio

scientific article published on 01 April 2007

Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

scientific article published on January 2008

Weight change and incident diabetes: addressing an unresolved issue.

scientific article published on 5 July 2010

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

scientific article published on 01 March 2019

You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses

scientific article published on 12 July 2016

List of works by Pieter M van Baal

A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

Cost-effectiveness of lifestyle modification in diabetic patients

DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact Assessments

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life.

Disability weights for comorbidity and their influence on health-adjusted life expectancy

Disease prevention: saving lives or reducing health care costs?

Does living longer in good health facilitate longer working lives? The relationship between disability and working lives

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.

Economic evaluation and the postponement of health care costs.

Economics and public health: engaged to be happily married!

Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.

Forecasting differences in life expectancy by education.

Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patterns

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis

Future costs in economic evaluation. A comment on Lee.

Future unrelated medical costs need to be considered in cost effectiveness analysis

Health care input constraints and cost effectiveness analysis decision rules.

Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level

Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective

Increasing tobacco taxes: A cheap tool to increase public health

Indirect estimation of chronic disease excess mortality.

Lifestyle intervention: from cost savings to value for money.

Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.

Mortality risk associated with disability: a population-based record linkage study

PAID 1.0 in Practice

Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

Probabilistic sensitivity analysis: be a Bayesian.

Quality of life and time to death: have the health gains of preventive interventions been underestimated?

Realistic Spatial Backcloth is not that Important in Agent Based Simulation Research

Should cost effectiveness analyses for NICE always consider future unrelated medical costs?

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention

The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA).

The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries.

The cost-effectiveness of increasing alcohol taxes: a modelling study.

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action

Time to death and the forecasting of macro-level health care expenditures: some further considerations

Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach.

To die with or from heart failure: a difference that counts

Trends in Dutch hospital spending by age and disease 1994-2010.

Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio

Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Weight change and incident diabetes: addressing an unresolved issue.

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses